Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological,...
-
San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological,...
-
L’EMA et la FDA acceptent d’évaluer les dossiers de demande d’autorisation de mise sur le marché de Gadopiclenol Examen prioritaire accordé par la FDA aux États-Unis28 mars 2022 Villepinte (France),...
-
Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA Priority Review granted by US-FDAMarch 28, 2022 Villepinte (France), March 29 2022 – Guerbet (FR0000032526...
-
DALLAS, March 29, 2022 (GLOBE NEWSWIRE) -- Environmental health technology company CASPR Technologies has beat two competing technologies in independent laboratory testing. Kansas-based Aerosol...
-
Pune, March 29, 2022 (GLOBE NEWSWIRE) -- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is used for genome editing. The rapid growth of genome editing can positively...
-
Ottawa, March 29, 2022 (GLOBE NEWSWIRE) -- The global facial injectable market size was accounted at US$ 12.25 billion in 2021. The traditional syringes, needle-free injectors, auto, and pen...
-
Los Angeles, CA, March 29, 2022 (GLOBE NEWSWIRE) -- (via Blockchain Wire) Satoshi Salon LA, a invite-only presentation of prescreened blockchain technology companies will take place at Zuber Lawler...
-
RICHMOND, Va., March 29, 2022 (GLOBE NEWSWIRE) -- Clinical trials are responsible for determining the safety and efficacy of drugs, and lead to virtually all standards of cancer care in the U.S....
-
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
-
Saniona Announces Strategic Program Prioritization and Restructuring to Streamline Operational Costs
PRESS RELEASE March 29, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced a strategic program reprioritization and restructuring...
-
Innovative women's health technology being developed by Aveta Life to be supported by ADM Tronics Northvale, NJ, March 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc....
-
SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now. A securities fraud class action has been...
-
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a...
-
— Multiple near-term anticipated product launches and development of innovative immuno-oncology pipeline position Coherus for long-term growth – — Introducing 2026 revenue target of $1.2...
-
ROSELAND, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
-
SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Ebvia, a biotechnology developing simple-to-use therapeutics for the treatment and prevention of COVID-19, today announces the publication entitled...
-
SAN DIEGO, CA, March 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that...
-
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
-
Expected to seek DSMB approval to proceed with EUA application to the FDA in Q2-2022 Ongoing regulatory package activities for submission to international regulatory authorities for drug approvals ...
-
REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
-
– Phase 3 ASSERT study on track to report topline data by the end of year – Albireo launches Expanded Access Program (EAP) for Alagille syndrome patients BOSTON, March 29, 2022 (GLOBE NEWSWIRE) --...
-
Phase 1 pharmacokinetics study demonstrates PHVS719 well tolerated with extended-release profile supporting once-daily dosingOrphan Drug Designation for PHA121 granted by FDARAPIDe-1, Phase 2...
-
ROSEVILLE, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire-- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
-
– Continue to advance and expand opportunities with established diversified development pipeline – Company ended the year with $65.3 million in cash, expected to fund operations through 2023 ...
-
SYDNEY, Australia, March 29, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to...
-
NORTH BILLERICA, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging...
-
Dosed first patient in VIP152 and pembrolizumab combination arm of study VNC-152-101 Preliminary findings in gynecologic malignancies will be presented as a poster at upcoming AACR Annual Meeting in...
-
IRVINE, Calif. and MIAMI, March 29, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used...
-
Results Highlight the Safety and Efficacy in Hard-to-Heal Wounds SAWC to Take Place in Phoenix, Arizona on April 6-10, 2022 YAVNE, Israel, March 29, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd....
-
ZURICH, Switzerland, March 29, 2022 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced that Philipp Probst,...
-
-- Apraglutide well-tolerated and does not require dose-adjustment in patients with severe renal disease -- -- Results demonstrate potential to reach 28% of SBS-IF patients with renal dysfunction who...
-
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Fisher Wallace Laboratories, the market leader in prescription wearable technology for the treatment of neuropsychiatric disorders, announces today the...
-
– Company on Track for Mid-year Filing of Investigational New Drug (IND) Application for Lead Candidate MRT-2359 – – Progressed NEK7 and CDK2 Molecular Glue Degrader Programs into Lead Optimization –...
-
CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
-
Orphazyme A/S in restructuringCompany announcementNo. 14/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 29, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH)...
-
SANTA BARBARA, Calif. and STOCKHOLM, Sweden, March 29, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today...
-
MISSISSAUGA, Ontario, March 29, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces investment in programs to...
-
EWING, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration...
-
Preclinical studies conducted with University of Pennsylvania’s Gene Therapy Program demonstrate biologic effects of vector-optimized gene therapy PBKR03 for Krabbe diseasePBKR03 showed marked...
-
CORNELIUS, N.C., March 29, 2022 (GLOBE NEWSWIRE) -- Valworx announced today the release of their new line of sanitary check valves. Valworx sanitary check valves feature Tri-Clamp ends for hygienic...
-
Meets Primary Endpoint With 58% Of Nyxol treated Subjects Returning to Baseline Pupil Diameter at 90 Minutes Compared to 6% of Placebo Subjects (p<0.0001) MIRA-3 Confirms Prior MIRA-2 Phase 3...
-
-- Achieved $11.2 Million in Net Revenue in 2021 ---- Expanded Coverage for EYSUVIS® to 118 Million Commercial Lives and 7.1 Million Medicare Lives ---- KPI-012 Phase 1b Clinical Data Accepted for...
-
NEW YORK and SALT LAKE CITY, March 29, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the proprietary Renalytix Accelerating Precision medicine In Diabetes (RAPID)...
-
BREXAFEMME® (ibrexafungerp tablets), launched in August 2021, achieved net revenues of $1.1 million in 2021. Fourth quarter 2021 net revenues were $0.6 million.As of the end of 2021, BREXAFEMME was...
-
Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program Expect topline data from cystic fibrosis Phase 2 expansion treatment...
-
-- Advancing late-stage clinical and preclinical programs of the Human Acellular Vessel™ (HAV™) and other engineered tissues across several indications – -- Multiple publications and scientific...
-
Pune, India, March 29, 2022 (GLOBE NEWSWIRE) -- According to MarketStudyReport, United States influenza vaccines market is anticipated to register a CAGR of 6.9% during the forecast period 2021-2030...
-
SAN DIEGO, March 29, 2022 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential breaches of fiduciary duty/or violations of federal and/or state law on behalf of Aquestive Therapeutics,...
-
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2022, Tumor Type, Distribution Channel, Drug Type" report has been added to ResearchAndMarkets.com's...